Company Overview

Item 9 Labs Corp. (OTC: INLB) is a cannabis-related holding company that historically operated through vertically integrated cultivation, production, dispensary, and franchising activities in the regulated U.S. cannabis industry. The company became known for combining branded cannabis products with a dispensary franchise model centered on the Unity Rd. retail platform. Its operations primarily targeted state-regulated medical and adult-use cannabis markets in the United States, with a focus on licensing, retail expansion, cultivation, and consumer packaged cannabis products.

The company evolved from cannabis cultivation and extraction activities in Arizona into a broader multi-state operating and franchising strategy. Through acquisitions and internal expansion efforts, Item 9 Labs sought to position itself as a cannabis retail infrastructure and brand-development company rather than solely a plant-touching operator. Public disclosures and market reporting indicate that the company experienced financial and operational challenges in recent years, including restructuring activity and reduced operational scale. Some current operational details are limited or inconsistent across public sources, and certain information regarding active business lines is inconclusive based on available public sources.

Business Operations

Item 9 Labs Corp. historically generated revenue through cannabis cultivation, processing, branded product sales, dispensary operations, and franchise-related activities. Its primary operating structure included the Item 9 Labs branded cannabis products business and the Unity Rd. cannabis dispensary franchise platform. The company’s franchise model was designed to support local dispensary operators with compliance systems, branding, operational guidance, procurement support, and retail development services in jurisdictions where cannabis sales are permitted under state law.

The company’s operations were primarily concentrated within the United States, particularly in Arizona and other state-regulated cannabis markets where franchise opportunities or retail expansion initiatives were pursued. Item 9 Labs also controlled cannabis-related intellectual property, cultivation assets, processing capabilities, and retail branding infrastructure through subsidiaries and affiliated entities. Public filings and corporate disclosures referenced strategic relationships with dispensary operators, franchisees, and cannabis license holders; however, the status and scale of several partnerships and operating assets have varied over time due to financial restructuring activity and changing market conditions.

Strategic Position & Investments

Item 9 Labs positioned itself strategically as a cannabis retail franchising and brand-development platform within the fragmented U.S. cannabis sector. A central component of this strategy was the expansion of the Unity Rd. franchise system, which aimed to provide a lower-capital market entry framework for dispensary operators while leveraging centralized branding and operational support. The company also pursued growth through acquisitions and consolidation efforts intended to expand its retail footprint and vertically integrated capabilities.

Historically, the company invested in cultivation infrastructure, extraction and processing operations, retail development, and franchise support systems. Public filings referenced efforts to scale branded cannabis products and establish recurring revenue through franchise fees and operational services. The company also explored opportunities tied to cannabis consumer packaged goods and regulated retail distribution channels. Due to ongoing financial pressures and operational restructuring disclosed in public markets, the long-term status of several investment initiatives and expansion programs remains uncertain based on currently available public information.

Geographic Footprint

Item 9 Labs Corp. maintained its headquarters in Arizona, with operational activities historically concentrated in the U.S. regulated cannabis market. The company’s cultivation, processing, and retail support activities were primarily associated with Arizona operations, while its franchising initiatives sought expansion opportunities across multiple U.S. states where cannabis regulations permitted dispensary licensing and commercial activity.

Through the Unity Rd. platform, the company pursued market presence in several regions of the United States, including parts of the Midwest, Southwest, and other state-level cannabis markets. Unlike larger multinational cannabis operators, Item 9 Labs did not maintain significant international cultivation or distribution operations based on available public disclosures. Its geographic influence was therefore primarily domestic and tied to state-by-state cannabis regulatory frameworks.

Leadership & Governance

Item 9 Labs Corp. was founded by cannabis industry entrepreneurs focused on vertically integrated operations and retail expansion within regulated U.S. cannabis markets. Leadership strategy historically emphasized scalable franchising, operational standardization, and development of nationally recognized cannabis retail and product brands. Public company governance was conducted through management leadership and a board structure typical of OTC-listed issuers, though executive turnover and restructuring activity have affected continuity in leadership reporting over time.

Key executives and leadership figures identified in public filings and company disclosures include:

• Andrew Bowden – Chief Executive Officer
• John Abbate – Former Chief Executive Officer
• Mason Rutherford – Former Chief Operating Officer
• Brian Kistler – Former Chief Financial Officer

Certain leadership appointments and executive roles have changed over time, and some current governance information is inconclusive based on available public sources and recent reporting.